HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $404,059 | +0.0% | 11,199 | 0.0% | 0.23% | -12.5% |
| Q2 2023 | $403,948 | -5.6% | 11,199 | 0.0% | 0.26% | +6.9% |
| Q1 2023 | $427,690 | -32.9% | 11,199 | 0.0% | 0.25% | -51.4% |
| Q4 2022 | $637,223 | -99.9% | 11,199 | 0.0% | 0.51% | +34.2% |
| Q3 2022 | $442,808,000 | -10.1% | 11,199 | 0.0% | 0.38% | -4.3% |
| Q2 2022 | $492,756,000 | +110136.2% | 11,199 | 0.0% | 0.40% | +55.7% |
| Q1 2022 | $447,000 | -99.9% | 11,199 | +25.8% | 0.26% | +83.5% |
| Q4 2021 | $357,828,000 | -1.2% | 8,899 | 0.0% | 0.14% | +21.9% |
| Q3 2021 | $362,011,000 | -25.4% | 8,899 | -16.7% | 0.11% | -19.1% |
| Q2 2021 | $485,115,000 | +8.9% | 10,683 | 0.0% | 0.14% | +11.9% |
| Q1 2021 | $445,374,000 | +48.1% | 10,683 | +51.7% | 0.13% | +68.0% |
| Q4 2020 | $300,764,000 | – | 7,042 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |